NYSE ARCA | ETF
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index.
It will normally invest at least 80% of its net assets in securities that comprise the underlying index.
The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of theU. S.
Food and Drug Administration clinical trials.
Top 20 Holdings
Asset | Name | Sector | Industry | Weight |
---|---|---|---|---|
VRNA | Verona Pharma PLC ADR | Healthcare | Biotechnology | 5.78% |
PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 5.51% |
CERE | Cerevel Therapeutics Holdings Inc | Healthcare | Biotechnology | 5.36% |
RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 4.38% |
ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 4.10% |
CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 4.07% |
AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 4.04% |
SMMT | Summit Therapeutics PLC | Healthcare | Biotechnology | 3.93% |
VKTX | Viking Therapeutics Inc | Healthcare | Biotechnology | 3.74% |
MRUS | Merus BV | Healthcare | Biotechnology | 3.61% |
KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 3.59% |
RYTM | Rhythm Pharmaceuticals Inc | Healthcare | Biotechnology | 3.44% |
RNA | Avidity Biosciences Inc | Healthcare | Biotechnology | 3.41% |
AKRO | Akero Therapeutics Inc | Healthcare | Biotechnology | 3.39% |
PTCT | PTC Therapeutics Inc | Healthcare | Biotechnology | 3.29% |
ACLX | Arcellx Inc | Healthcare | Biotechnology | 3.08% |
ACAD | ACADIA Pharmaceuticals Inc | Healthcare | Biotechnology | 2.97% |
IMVT | Immunovant Inc | Healthcare | Biotechnology | 2.89% |
ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 2.73% |
ZLAB | Zai Lab Ltd | Healthcare | Biotechnology | 2.69% |